Varian Sinks $15M into Augmenix, Inks Purchase Option

Publicly traded Varian Medical Systems Inc., a supplier of medical technology for treating cancer with radiotherapy, has poured $15 million into venture-backed Augmenix, sealing a minority stake and an option to buy the company. Waltham, Mass.-based Augmenix is developing hydrogel products to improve outcomes in radiation oncology. The company is backed by investors including Ascension Health Ventures, Catalyst Health Ventures, Pinnacle Ventures, and the Sparta Group.

North AmericaUSBriefs